333 related articles for article (PubMed ID: 28389593)
1. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
[TBL] [Abstract][Full Text] [Related]
2. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice.
Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY
Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969
[TBL] [Abstract][Full Text] [Related]
3. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
4. Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis.
Morimura S; Sugaya M; Oka T; Suga H; Miyagaki T; Tsunemi Y; Asano Y; Sato S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670758
[TBL] [Abstract][Full Text] [Related]
5. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
[TBL] [Abstract][Full Text] [Related]
8. Decryption of Active Constituents and Action Mechanism of the Traditional Uighur Prescription (BXXTR) Alleviating IMQ-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice.
Pang X; Zhang K; Huang J; Wang H; Gao L; Wang T; Sun Y; Chen L; Wang J
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933541
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
[TBL] [Abstract][Full Text] [Related]
10. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
11. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
[TBL] [Abstract][Full Text] [Related]
12. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
14. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
16. Gold lotion from citrus peel extract ameliorates imiquimod-induced psoriasis-like dermatitis in murine.
Lin CC; Wu JJ; Pan YG; Chao YH; Lin FC; Lee YR; Chu CL
J Sci Food Agric; 2018 Nov; 98(14):5509-5517. PubMed ID: 29691866
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
18. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
19. Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Chen T; Fu LX; Guo ZP; Yin B; Cao N; Qin S
J Dermatol; 2017 May; 44(5):573-581. PubMed ID: 27943400
[TBL] [Abstract][Full Text] [Related]
20. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]